https://doi.org/10.4081/hmr.v1i6.684

Immunoglobuline anti-D endovena: una nuova opzione per la porpora trombocitopenica idiopatica

Vol. 1 No. 6: XXXIV Congresso Nazionale Società Italiana Ematologia Oncologia Pediatrica
Published: June 22, 2009
Abstract Views: 404
PDF: 4694
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

G Russo
support@pagepress.org
La porpora trombocitopenica idiopatica (PTI) è una malattia caratterizzata da una accelerata distruzione piastrinica immuno-mediata. La malattia si presenta con una piastrinopenia isolata, in assenza di altre apparenti cause di piastrinopenia, quali infezioni, malattie autoimmuni sistemiche, assunzione di farmaci, neoplasie etc. La PTI in età pediatrica è, nella maggior parte dei casi, una malattia autolimitantesi, con completa e definitiva risoluzione nell’80-90% dei casi entro i 6 mesi dalla diagnosi. Il restante 10-20% di pazienti, in cui la piastrinopenia persiste per più di 6 mesi, viene considerato affetto da PTI cronica.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Russo, G. (2009). Immunoglobuline anti-D endovena: una nuova opzione per la porpora trombocitopenica idiopatica. Hematology Meeting Reports (formerly Haematologica Reports), 1(6). https://doi.org/10.4081/hmr.v1i6.684
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).